Clinical Trials Browser

decitabine and cedazuridine drug combination × Lymphoid × 90 days × Clear all

NCT05272384 2026-05-13

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse